Target intelligence / Profile preview

Bromodomain-Containing Protein Family (BRD)

Target
BRD
Molecular classification
Epigenetic reader, Transcription factor, Chromatin regulator
01

Overview

The bromodomain-containing protein family comprises proteins that possess at least one bromodomain, a conserved structural motif that specifically recognizes and binds to acetylated lysine residues, primarily on histone tails. Through this recognition, bromodomain-containing proteins act as "readers" of epigenetic marks and play crucial roles in regulating gene expression by facilitating chromatin remodeling and transcriptional activation or repression. They are classified into families like BET and non-BET proteins, with diverse functions in cell proliferation, differentiation, DNA damage repair, and oncogenesis. Different bromodomain subfamilies exhibit distinct histone recognition specificities. The family members are central regulators in epigenetics due to their ability to interpret lysine acetylation signals on histones—a key mechanism underlying dynamic changes in gene expression during development and disease states such as cancer.

Other names
Bromodomain proteinsBRD proteinsBromodomain-containing proteins
02

Mechanism of action

Binding to acetylated lysine residues on histones, thereby modulating gene transcription.

03

Biological functions

Gene expression regulationChromatin remodelingTranscription activationTranscription repressionCell proliferationCell differentiationDNA damage repairViral infection cycle regulation
04

Disease associations

CancerInflammation
05

Safety considerations

Potential for broad epigenetic effectsOff-target effectsDevelopment of resistance
06

Interacting drugs

BET inhibitors (e.g., JQ1, I-BET151)

Beyond the preview

Go deeper on Bromodomain-Containing Protein Family (BRD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bromodomain-Containing Protein Family (BRD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call